Amnion grafts to keep nipples healthy after removal surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether using a special membrane (amnion allograft) during nipple-sparing mastectomy helps keep the nipple healthy and alive after surgery. It may help people having gender-affirming chest surgery or those reducing breast cancer risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 15 or older if you are a transgender man (female-to-male) planning chest surgery.
- Or you must be between 18 and 75 and planning to have both nipples preserved during surgery to lower breast cancer risk or for non-cancer reasons.
- You cannot be currently taking steroid medications.
- You cannot have a connective tissue disorder (like lupus or Marfan syndrome).
- You cannot have a history of breast cancer, previous chest radiation, or neuropathy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if injecting a gel-like substance (hyaluronic acid) can improve nipple reconstruction in women who have had mastectomies. It aims to see if this method works better than or alongside tattoos for rebuilding the nipple-areola area.
This trial tests a product called Plexaa, which is applied before surgery to help prepare the skin and improve healing. It is for transgender or non-binary people having a specific type of mastectomy (breast removal) for gender affirmation.
This study tests whether adding a nerve graft during nipple-sparing mastectomy with implant reconstruction helps restore feeling in the breast after surgery. It compares sensation outcomes in patients who receive the graft versus those who do not.
This trial is testing a surgical technique to reconnect nerves in the nipple and areola after a mastectomy, aiming to restore feeling. It is for women with breast cancer who are having a nipple-sparing mastectomy with implant reconstruction.
This trial tests whether it is safe to keep the areola (the dark area around the nipple) when the nipple itself has cancer cells. It may help women who want a more natural look after breast removal and reconstruction.
This trial tests a minimally invasive surgical technique that removes breast tissue while preserving the nipple and immediately reconstructing the breast. It may be suitable if you have early-stage breast cancer or are at high genetic risk and need preventive breast removal.
Hear when a new Mastectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.